Loading...
Please wait, while we are loading the content...
Similar Documents
Primary Prevention of Atrial Fibrillation where are we in 2012?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Imazio, Massimo |
| Copyright Year | 2012 |
| Abstract | Drugs to alter or delay myocardial remodelling associated with heart failure, hypertension, or inflammation in the post-operative setting, may prevent the development of atrial fibrillation. Current experimental and clinical evidences support specific treatments for defined patient population (i.e. ACE-inhibitors and ARB for chronic heart failure and hypertension expecially with LV hypertrophy; statins, corticosteroids and possibly colchicine after cardiac surgery). |
| Starting Page | 608 |
| Ending Page | 608 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.jafib.com/published/webFormat/Imazio/imazio.pdf |
| PubMed reference number | 28496763v1 |
| Alternate Webpage(s) | https://doi.org/10.4022/jafib.608 |
| DOI | 10.4022/jafib.608 |
| Journal | Journal of atrial fibrillation |
| Volume Number | 5 |
| Issue Number | 2 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Adrenal Cortex Hormones Amiodarone Angiotensin II receptor antagonist Angiotensin-Converting Enzyme Inhibitors Atrial Fibrillation Calcium Cardiac Surgery procedures Cardiomyopathies Colchicine Fibrosis Handling (Psychology) Heart Atrium Heart Diseases Heart failure High Risk Acute Leukemia Hypertensive disease Hypertrophy Iontophoresis Oxidative Stress Patients Pharmacology Postoperative Complications Promotion (action) Simvastatin Ventricular Dysfunction Ventricular Dysfunction, Left |
| Content Type | Text |
| Resource Type | Article |
